NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $355,655 | -28.8% | 8,570 | +3.2% | 0.00% | -40.0% |
| Q1 2023 | $499,342 | -18.0% | 8,303 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $609,025 | -13.0% | 8,303 | -9.8% | 0.01% | -12.5% |
| Q3 2022 | $700,000 | -6.8% | 9,210 | -14.7% | 0.01% | +14.3% |
| Q2 2022 | $751,000 | -37.2% | 10,802 | -25.1% | 0.01% | -12.5% |
| Q1 2022 | $1,195,000 | -2.6% | 14,425 | -11.7% | 0.01% | +14.3% |
| Q4 2021 | $1,227,000 | -38.7% | 16,336 | -5.2% | 0.01% | -41.7% |
| Q3 2021 | $2,002,000 | -47.0% | 17,231 | +1.2% | 0.01% | -47.8% |
| Q2 2021 | $3,777,000 | +101.8% | 17,027 | +20.2% | 0.02% | +76.9% |
| Q1 2021 | $1,872,000 | -25.5% | 14,162 | -2.4% | 0.01% | -27.8% |
| Q4 2020 | $2,512,000 | – | 14,515 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |